Cytosorbents (CTSO) Treasury Shares (2012 - 2026)
Cytosorbents (CTSO) posted Treasury Shares of $2.6 million for Q1 2026, down 4.3% on a QoQ basis from $2.8 million in Q4 2025, and down 5.45% year-over-year from $2.8 million in Q1 2025.
Cytosorbents (CTSO) Treasury Shares (2012 - 2026) Analysis & Trends
Cytosorbents' Treasury Shares history runs 12 years deep, the most recent figure standing at $2.6 million for Q1 2026.
- Quarterly Treasury Shares fell 5.45% year-over-year to $2.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.6 million (down 5.45% YoY) and the FY2025 annual result came in at $2.8 million, down 1.98% from the prior year.
- Treasury Shares was $2.6 million for Q1 2026 at Cytosorbents, down from $2.8 million in the prior quarter.
- Across five years, Treasury Shares topped out at $2.8 million in Q4 2023 and bottomed at $125340.0 in Q2 2022.
- A 5-year average of $992830.5 and a median of $547335.0 in 2025 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2023 — Treasury Shares surged 804.7% — and 2024, when it slumped 77.29%.
- Cytosorbents' Treasury Shares stood at $312092.0 in 2022, then jumped by 804.7% to $2.8 million in 2023, then slumped by 77.29% to $641336.0 in 2024, then jumped by 329.42% to $2.8 million in 2025, then fell by 4.3% to $2.6 million in 2026.
- Business Quant data shows CTSO's Treasury Shares at $2.6 million in Q1 2026, $2.8 million in Q4 2025, and $810300.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 16.94 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 7.70 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 263.29 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 83.00 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.12 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 14.05 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 4.51 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 515.00 Mn |
| 10 | Cytosorbents | 22.58 Mn | 17.78 Mn | 6.13 Mn | 2.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.64 Mn |
| Mar 31, 2026 | 2.64 Mn |
| Dec 31, 2025 | 2.75 Mn |
| Dec 31, 2025 | 2.75 Mn |
| Sep 30, 2025 | 810,300.00 |
| Sep 30, 2025 | 810,300.00 |
| Jun 30, 2025 | 547,335.00 |
| Jun 30, 2025 | 547,335.00 |
| Mar 31, 2025 | 2.79 Mn |
| Mar 31, 2025 | 2.79 Mn |
| Dec 31, 2024 | 641,336.00 |
| Dec 31, 2024 | 641,336.00 |
| Sep 30, 2024 | 641,336.00 |
| Sep 30, 2024 | 641,336.00 |
| Jun 30, 2024 | 743,505.00 |
| Jun 30, 2024 | 743,505.00 |
| Mar 31, 2024 | 460,505.00 |
| Mar 31, 2024 | 460,505.00 |
| Dec 31, 2023 | 2.82 Mn |
| Dec 31, 2023 | 2.82 Mn |